502,363
Participants
Start Date
October 4, 2017
Primary Completion Date
May 31, 2024
Study Completion Date
May 31, 2024
Albendazole
All eligible individuals will receive a single dose of 400 mg albendazole.
Institut de Recherche pour le Développement, Comé
Christian Medical College, Vellore
London School of Hygiene and Tropical Medicine, Mangochi
Bill and Melinda Gates Foundation
OTHER
Imperial College London
OTHER
London School of Hygiene and Tropical Medicine
OTHER
Institut de Recherche Clinique du Bénin (IRCB)
UNKNOWN
Institut de Recherche pour le Developpement
OTHER_GOV
Christian Medical College, Vellore, India
OTHER
Blantyre Institute for Community Ophthalmology (BICO)
UNKNOWN
Swiss Tropical & Public Health Institute
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Washington
OTHER